Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Change in Receivables (2016 - 2017)

Anaptysbio (ANAB) has disclosed Change in Receivables for 2 consecutive years, with -$1.2 million as the latest value for Q1 2017.

  • For the quarter ending Q1 2017, Change in Receivables fell 3400.0% year-over-year to -$1.2 million, compared with a TTM value of -$1.2 million through Dec 2017, down 122400.0%, and an annual FY2017 reading of -$1.2 million, down 122400.0% over the prior year.
  • Change in Receivables was -$1.2 million for Q1 2017 at Anaptysbio, down from $365000.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $365000.0 in Q4 2016 and bottomed at -$1.2 million in Q1 2017.